Home Other Building Blocks Pirodavir

Pirodavir

CAS No.:
124436-59-5
Catalog Number:
AG000M0M
Molecular Formula:
C21H27N3O3
Molecular Weight:
369.4574
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
1mg
98%(HPLC)
In Stock USA
United States
$54
- +
5mg
98%(HPLC)
In Stock USA
United States
$141
- +
10mg
98%(HPLC)
In Stock USA
United States
$246
- +
25mg
98%(HPLC)
In Stock USA
United States
$540
- +
Product Description
Catalog Number:
AG000M0M
Chemical Name:
Pirodavir
CAS Number:
124436-59-5
Molecular Formula:
C21H27N3O3
Molecular Weight:
369.4574
MDL Number:
MFCD00866965
IUPAC Name:
ethyl 4-[2-[1-(6-methylpyridazin-3-yl)piperidin-4-yl]ethoxy]benzoate
InChI:
InChI=1S/C21H27N3O3/c1-3-26-21(25)18-5-7-19(8-6-18)27-15-12-17-10-13-24(14-11-17)20-9-4-16(2)22-23-20/h4-9,17H,3,10-15H2,1-2H3
InChI Key:
KCHIOGFOPPOUJC-UHFFFAOYSA-N
SMILES:
CCOC(=O)c1ccc(cc1)OCCC1CCN(CC1)c1ccc(nn1)C
UNII:
BML697718K
Properties
Complexity:
446  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
369.205g/mol
Formal Charge:
0
Heavy Atom Count:
27  
Hydrogen Bond Acceptor Count:
6  
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
369.465g/mol
Monoisotopic Mass:
369.205g/mol
Rotatable Bond Count:
8  
Topological Polar Surface Area:
64.6A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
3.7  
Literature
Title Journal
Study of the biological activity of novel synthetic compounds with antiviral properties against human rhinoviruses. Molecules (Basel, Switzerland) 20110426
Pharmacophore-based design, synthesis, and biological evaluation of novel chloro-pyridazine piperazines as human rhinovirus (HRV-3) inhibitors. Bioorganic & medicinal chemistry letters 20110201
[Establishment of isolated rabbit airway smooth muscles responsiveness model for the pharmacodynamic study of anti-rhinoviruses drugs]. Yao xue xue bao = Acta pharmaceutica Sinica 20100401
Synthesis and evaluation of novel chloropyridazine derivatives as potent human rhinovirus (HRV) capsid-binding inhibitors. Bioorganic & medicinal chemistry 20090115
Isothiazole derivatives as antiviral agents. Antiviral chemistry & chemotherapy 20070101
2-Ethoxybenzoxazole as a bioisosteric replacement of an ethyl benzoate group in a human rhinovirus (HRV) capsid binder. Bioorganic & medicinal chemistry letters 20050415
In vitro activity of expanded-spectrum pyridazinyl oxime ethers related to pirodavir: novel capsid-binding inhibitors with potent antipicornavirus activity. Antimicrobial agents and chemotherapy 20040501
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 8. Pharmacological optimization of orally bioavailable 2-pyridone-containing peptidomimetics. Journal of medicinal chemistry 20031009
An orally bioavailable oxime ether capsid binder with potent activity against human rhinovirus. Journal of medicinal chemistry 20030717
Synthesis of new 3-methylthio-5-aryl-4-isothiazolecarbonitriles with broad antiviral spectrum. Antiviral research 20020801
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 6. Structure-activity studies of orally bioavailable, 2-pyridone-containing peptidomimetics. Journal of medicinal chemistry 20020411
The viral protein 3CD induces an equilibrium between the viral protein and RNA synthesis in a cell-free system for poliovirus replication. Archives of virology 20020401
In vitro antiviral activity of AG7088, a potent inhibitor of human rhinovirus 3C protease. Antimicrobial agents and chemotherapy 19991001
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 4. Incorporation of P1 lactam moieties as L-glutamine replacements. Journal of medicinal chemistry 19990408
In vitro studies of the antirhinovirus activity of soluble intercellular adhesion molecule-1. Antimicrobial agents and chemotherapy 19920601
In vitro activity of pirodavir (R 77975), a substituted phenoxy-pyridazinamine with broad-spectrum antipicornaviral activity. Antimicrobial agents and chemotherapy 19920101
Properties